Results 281 to 290 of about 15,014,800 (402)

A manifesto for a globally diverse, equitable, and inclusive open science. [PDF]

Commun Psychol
Ghai S, Thériault R, Forscher P, Shoda Y, Syed M, Puthillam A, Peng HC, Basnight-Brown D, Majid A, Azevedo F, Singh L.   +10 more
europepmc   +1 more source

Open Science at PLOS Pathogens. [PDF]

PLoS Pathog, 2023
Cadwallader L, Haldar K, Kirk R, Mabbott NA, Malim MH.   +4 more
europepmc   +1 more source

"The father of open source science"

, 2005
Peter Suber
openalex   +1 more source

Construction of Web 2.0 based Open Archiving Community for Life Science [PDF]

, 2006
Bu Yeong Ahn, Eung-Bong Lee, Jeong-Min Han   +2 more
openalex   +1 more source

Addressing persistent challenges in digital image analysis of cancer tissue: resources developed from a hackathon

Molecular Oncology, EarlyView.
Large multidimensional digital images of cancer tissue are becoming prolific, but many challenges exist to automatically extract relevant information from them using computational tools. We describe publicly available resources that have been developed jointly by expert and non‐expert computational biologists working together during a virtual hackathon
Sandhya Prabhakaran, Clarence Yapp, Gregory J. Baker, Johanna Beyer, Young Hwan Chang, Allison L. Creason, Robert Krueger, Jeremy Muhlich, Nathan Heath Patterson, Kevin Sidak, Damir Sudar, Adam J. Taylor, Luke Ternes, Jakob Troidl, Xie Yubin, Artem Sokolov, Darren R. Tyson   +16 more
wiley   +1 more source

Structuring data analysis projects in the Open Science era with Kerblam! [PDF]

F1000Res
Visentin L, Munaron L, Ruffinatti FA.
europepmc   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

The European Open Science Cloud as a common good Potentials and limitations of this endeavour. [PDF]

Open Res Eur
Bertelli A, Acciai M, Rossi G.
europepmc   +1 more source

Open Science: Open Source Licences in Scientific Research

, 2005
Andrés Guadamuz
openalex   +2 more sources

Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer

Molecular Oncology, EarlyView.
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu, Fenglin Shen, Yang Liu, Ziqing Zhong, Yongling Chen, Zhiyuan Xia, Cuiju Mo, Hongxiu Yu   +7 more
wiley   +1 more source